Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/04/2012CA2830822A1 Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
10/04/2012CA2830811A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients
10/04/2012CA2830639A1 Use of compounds isolated from morus bark
10/04/2012CA2830549A1 Methods and compositions for preparing noribogaine from voacangine
10/04/2012CA2830447A1 New azaspirodecanone compounds as hsl inhibitors
10/04/2012CA2830148A1 Novel furanone derivatives
10/04/2012CA2830112A1 Selection of hcv treatment
10/04/2012CA2830027A1 Novel bicyclic pyridinones
10/04/2012CA2829860A1 Pyrrole derivatives as nicotinic acetylcholine receptor modulators for use in the treatment of neurodegenerative disorders such as alzheimer's and parkinson's disease
10/04/2012CA2829791A1 Sustained-release injectable formulation
10/04/2012CA2829280A1 Compositions of opioid antagonists and their use for treating scleroderma
10/04/2012CA2829240A1 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
10/04/2012CA2829229A1 Nutritional compositions for increasing arginine levels and methods of using same
10/04/2012CA2828824A1 Thiazolopyrimidine compounds
10/04/2012CA2828700A1 Pharmaceutical composition containing block copolymer comprising boronic acid compound
10/04/2012CA2828423A1 3-ureidoisoquinolin-8-yl derivatives
10/04/2012CA2827455A1 Process for the production of a pemetrexed salt
10/04/2012CA2827214A1 Lipoxygenase inhibitors
10/04/2012CA2826404A1 Method for producing phenoxypyridine derivative
10/04/2012CA2822177A1 Nanoparticles loaded with chemotherapeutic antitumoral drug
10/03/2012EP2505645A1 MicroRNA as a cancer progression predictor and its use for treating cancer
10/03/2012EP2505589A1 Novel sphingolipid heterocyclic compounds as modulators of sphingolipid signaling and uses thereof
10/03/2012EP2505588A1 Process for preparing aminomethyl azaadamantane derivatives as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (NNRS)
10/03/2012EP2505587A1 Method for manufacturing a 6-substituted-1-methyl-1h-benzimidazole derivative, and manufacturing intermediate from said method
10/03/2012EP2505586A1 Indole compound and pharmaceutical use thereof
10/03/2012EP2505583A1 Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
10/03/2012EP2505579A2 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/03/2012EP2505578A2 Methods and Compounds for Producing Dipeptidyl Peptidase IV Inhibitors and Intermediates thereof
10/03/2012EP2505202A1 D-myo-inositol 3,4,5,6-tetrakisphosphate to modulate thrombin/antithrombin activity by heparin binding
10/03/2012EP2505201A1 Trmp5 inhibitors support body weight reduction without reducing food intake
10/03/2012EP2505200A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of scleroderma
10/03/2012EP2505199A1 Modifying pirfenidone treatment for patients with atypical liver function
10/03/2012EP2505198A1 Compounds for use as therapeutic agents affecting p53 expression and/or activity
10/03/2012EP2505197A1 Treatment of ADHD
10/03/2012EP2505196A1 Antithrombotic agent
10/03/2012EP2505195A1 Topical pharmaceutical compositions of ketoprofen and methylsulfonylmethane
10/03/2012EP2505194A2 Nicotine-containing patch preparation
10/03/2012EP2505193A1 Anti - retroviral combination
10/03/2012EP2505191A1 Lyophilized Carbapenem antibiotic composition
10/03/2012EP2505190A1 Polymorphic forms of ertapenem monosodium salt and process for it's preparation
10/03/2012EP2505188A1 Suppository for rectal, vaginal or urethral administration
10/03/2012EP2505060A2 New disinfectant mixture of alcool and glycerol ether for the control of mycobacteria
10/03/2012EP2504703A1 Immunomodulatory compounds for the restoration of vitamin d sensitivity in vitamin d resistant tumor cells
10/03/2012EP2504452A1 Materials and methods useful for affecting tumor cell growth, migration and invasion
10/03/2012EP2504435A1 Sirna compounds comprising terminal substitutions
10/03/2012EP2504434A1 Pharmaceutical composition comprising mirna-100 and its use in the modulation of blood vessel growth and endothelial inflammation
10/03/2012EP2504370A1 Acrylic or methacrylic polymer including alpha-tocopherol grafts
10/03/2012EP2504344A1 Hepatitis c inhibitor compounds
10/03/2012EP2504343A1 Hepatitis c inhibitor compounds
10/03/2012EP2504342A1 Imidazo-pyrazoles as gpr119 inhibitors
10/03/2012EP2504341A1 A new crystalline form of pemetrexed disodium
10/03/2012EP2504340A1 Crystalline forms of substituted pyrazolopyrimidines
10/03/2012EP2504339A1 Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
10/03/2012EP2504338A1 Pyridine-pyridinone derivatives, preparation and therapeutic use thereof
10/03/2012EP2504337A1 Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate
10/03/2012EP2504336A1 Novel naphthyridine derivatives and the use thereof as kinase inhibitors
10/03/2012EP2504333A1 Morpholinothiazoles as alpha 7 positive allosteric modulators
10/03/2012EP2504332A1 An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
10/03/2012EP2504331A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
10/03/2012EP2504330A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
10/03/2012EP2504329A1 5-alkynyl-thiophene-2-carboxylic acid derivatives and their use for the treatment or prevention of flavivirus infections
10/03/2012EP2504328A1 Novel compounds as receptor modulators with therapeutic utility
10/03/2012EP2504327A1 Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions
10/03/2012EP2504326A1 Sialochimeric compounds
10/03/2012EP2504324A1 Sultam derivatives
10/03/2012EP2504323A1 Novel compounds as receptor modulators with therapeutic utility
10/03/2012EP2504319A1 Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative
10/03/2012EP2504318A2 Crystalline salt forms of a pyrimidin-5-yl acetic acid derivative
10/03/2012EP2504317A1 Potassium channel modulators
10/03/2012EP2504316A1 Heterocylic compounds as antagonists of the orexin receptors
10/03/2012EP2504315A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
10/03/2012EP2504314A1 Quinazoline derivatives
10/03/2012EP2504313A1 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof
10/03/2012EP2504311A1 Arachidonic acid analogs and methods for analgesic treatment using same
10/03/2012EP2504034A1 Topical ibuprofen formulations
10/03/2012EP2504033A1 Film-like pharmaceutical dosage forms
10/03/2012EP2504025A2 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
10/03/2012EP2504016A1 Inhibition of pancreatic lipase
10/03/2012EP2504015A2 Socs3 inhibition promotes cns neuron regeneration
10/03/2012EP2504014A1 Modulation of epidermal growth factor receptor ligands
10/03/2012EP2504013A1 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
10/03/2012EP2504012A2 Use of an oleo gel containing triterpene for healing wounds
10/03/2012EP2504011A2 Methods for treating mild cognitive impairment
10/03/2012EP2504010A1 Fused bicyclic pyrimidine derivatives and methods of use thereof
10/03/2012EP2504009A1 Methods and compositions for the treatment of psychotic disorders through the identification of the sult4a1-1 haplotype
10/03/2012EP2504008A1 Methods and assays for the treatment of irritable bowel syndrome
10/03/2012EP2504007A1 Novel therapeutic methods for treating inflammation and immune system disorders
10/03/2012EP2504006A1 Compositions comprising amino acids for treating chronic obstructive pulmonary disease
10/03/2012EP2504005A1 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
10/03/2012EP2504004A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina
10/03/2012EP2504003A1 Nitroxyl donors for the treatment of pulmonary hypertension
10/03/2012EP2504002A1 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
10/03/2012EP2504001A1 Combination for the treatment of radiation - or chemotherapy - induced mucositis
10/03/2012EP2504000A1 Transcription factor inhibitors and related compositions, formulations and methods
10/03/2012EP2503999A1 Pharmaceutical composition comprising propofol
10/03/2012EP2503998A1 Dermatological compositions comprising a fat or oil of an essential fatty acid triglyceride
10/03/2012EP2503997A1 Inhibitors of the pp1/gadd34 complex for the treatment of a condition requiring an immunosuppressive activity
10/03/2012EP2503994A1 Pharmaceutical compositions comprising sigma receptor ligands
10/03/2012EP2503993A1 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts
10/03/2012EP2503991A1 Liquid pharmaceutical compositions
1 ... 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 ... 7860